Key clinical point: Patients with psoriasis often have undiagnosed psoriatic arthritis and need better screening.
Major finding: In all, 12.4% of patients had a positive screen for possibly undiagnosed psoriatic arthritis but had never been diagnosed with the disease.
Study details: Prospective study of the validated Psoriasis Epidemiology Screening Tool (PEST) in 904 patients in the Corrona PsO Registry who had not been previously diagnosed with psoriatic arthritis.
Disclosures: Corrona and Novartis designed and conducted the study. Novartis, the chief funder, participated in data analysis and manuscript review. Dr. Mease disclosed research funding from Novartis and several other pharmaceutical companies. He also disclosed consulting and speakers bureau fees from Novartis, Corrona, and several other companies.
Mease PJ et al. J Eur Acad Dermatol Venereol. 2019 Mar 5. doi: 10.1111/jdv.15443.